Secondary prevention: Long-term effects of angiotensin-converting enzyme inhibitors and calcium antagonists on the right and left ventricles in essential hypertension

American Heart Journal

Volumn 134, Issue 3, 1997, Pages 557-564

  Lombardo, M ^a   Alli, C ^a   Broccolino, M ^a   Ferrai, S ^a   Montemurro, L ^a   Zaini, G ^a   Zanni, D ^a  

^a NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; ISRADIPINE; NICARDIPINE; NIFEDIPINE; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BICYCLE ERGOMETRY; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HEART RIGHT VENTRICLE FUNCTION; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; BLOOD PRESSURE MEASUREMENT; DRUG EFFECT; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART MUSCLE; HEART VENTRICLE FUNCTION; HYPERTENSION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

ADULT; AMLODIPINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; CALCIUM CHANNEL BLOCKERS; ECHOCARDIOGRAPHY; FEMALE; FOSINOPRIL; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIUM; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION;

EID: 0031228267     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(97)70095-4     Document Type: Article

References (42)

1. Y Sugishita K Iida K Yukisada I Ito Cardiac determinants of regression of left ventricular hypertrophy in essential hypertension with antihypertensive treatment J Am Coll Cardiol 15 1990 665 671
2. B Chevalier EL Callens F Amrani C Heymes B Swynghedauw Molecular basis of regression of cardiac hypertrophy Am J Cardiol 73 1994 10C 17C
3. PR Liebson CA Grandits S Dianzumba for the TOMHS Study Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the treatment of mild hypertension Circulation 91 1995 698 706
4. B Dahlof K Pennert L Hansson Reversal of left ventricular hypertrophy in hypertensive patients: a meta-analysis of 109 treatment studies J Hypertens 12 1992 95 110
5. JM Cruickshank J Lewis V Moore C Dodd Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy J Hum Hypertens 6 1992 85 90
6. RE Schmieder P Martus D Klingbeil Reversal of left ventricular hypertrophy in essential hypertension: a meta-analysis of randomized double-blind studies JAMA 275 1996 1507 1513
7. CD Furberg BM Psaty Calcium-antagonists: not appropriate as first-line antihypertensive agents Am J Hypertens 9 1996 122 125
8. HC Dittrich LC Chow PH Nicod Early improvement in left ventricular diastolic function after relief of chronic right ventricular pressure overload Circulation 80 1989 823 830
9. D Aristizabal F Messerli ED Frohlich Disparate structural effects on left and right ventricles by angiotensin-converting enzyme inhibitors and calcium antagonists in essential hypertension Am J Cardiol 73 1994 483 487
10. R Foale P Nihoyannopulos W McKenna Echocardiographic measurement of the normal adult ventricle Br Heart J 56 1986 33 44
11. DJ Sahn A De Maria J Kisslo A Weiman The Committee on M-mode Standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements Circulation 58 1978 1072 1083
12. G Kan CA Visser KI Lie D Durrer Left ventricular volumes and ejection fraction by single plane two-dimensional apex echocardiography Eur Heart J 2 1981 339 343
13. RB Devereux DR Alonso EM Lutas Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am J Cardiol 57 1986 450 458
14. AL Klein LK Hatle DJ Burstow Doppler characterization of left ventricular diastolic function in cardiac amyloidosis J Am Coll Cardiol 13 1989 1017 1026
15. AL Klein LK Hatle DJ Burstow Comprehensive Doppler assessment of right ventricular diastolic function in cardiac amyloidosis J Am Coll Cardiol 15 1990 99 108
16. W Meyer-Sabellek KL Schulte R Gotzen Non-invasive ambulatory blood pressure monitoring: technical possibilities and problems J Hypertens 8 suppl 1990 s3 s10
17. The National High Blood Pressure Education Program Coordinating Committee National High Blood Pressure Education Program Working Group report on ambulatory blood pressure monitoring Arch Intern Med 150 1990 2270 2280
18. LJ Appel PK Whelton AJ Seider AR Patel MJ Klag The accuracy and precision of the Accutracker ambulatory blood pressure monitor Am J Epidemiolol 132 1990 343 354
19. WB White HM Dey P Schulman Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension Am Heart J 118 1989 782 795
20. S Izumo B Nadal-Ginard V Mahdavi Proto-oncogene induction and reprogramming of cardiac gene expression produced by pressure overload J Clin Invest 85 1994 339 343
21. BG Zimmerman EG Sybert PL Wong Interaction between sympathetic and renin-angiotensin-system J Hypertens 2 1984 581 588
22. G Muiesan E Agabiti-Rosei G Romanelli ML Muiesan M Castellano M Beschi Adrenergic activity and left ventricular function during treatment of essential hypertension with calcium antagonists Am J Cardiol 57 1986 44D 49D
23. EC Bielen R Fagard PJ Lijnen TM Tjandra-Maga R Verbesselt AK Amery Comparison of the effects of isradipine and lisinopril on left ventricular structure and function in essential hypertension Am J Cardiol 69 1992 1200 1206
24. RA Phillips M Ardeljan S Shimabukuro Normalization of left ventricular mass and associated changes in neurohormones and atrial natriuretic peptide after 1 year of sustained nifedipine therapy for severe hypertension J Am Coll Cardiol 17 1991 1595 1602
25. R De Vries M Querè D Lok Comparison of effects on peak oxygen consumption, quality of life, and neurohormones of felodipine and enalapril in patients with congestive heart failure Am J Cardiol 76 1995 1253 1258
26. LP Krussell LT Jespersen A Schmitz K Thomsen PO Lederhalle Repetitive natriuresis and blood pressure: long-term calcium entry blockade with isradipine Hypertension 10 1987 577 581
27. JH Pratt DA Turner JA McAteer DP Henry Beta-adrenergic stimulation of aldosterone production by rat adrenal capsular explants Endocrinology 117 1985 1189 1194
28. M Bignotti G Gaudio G Gorini O Rinaldi AM Grandi A Venco Effects of sustained-release isradipine on left ventricular anatomy and function in systemic hypertension Am J Cardiol 72 1993 1301 1304
29. GB Habib DL Mann WA Zoghbi Normalization of cardiac structure and function after regression of cardiac hypertrophy Am Heart J 128 1994 333 343
30. HC Dittrich J Adler J Ong M Reitman M Weber M Ziegler Effects of sustained-release nicardipine on regression of left ventricular hypertrophy in systemic hypertension Am J Cardiol 6 1992 1559 1564
31. S Savonitto M Bevilacqua E Chebat β-Adrenergic receptors and reflex tachycardia after single and repeated felodipine administration in essential hypertension J Cardiovasc Pharmacol 17 1991 970 975
32. FH Leenen DL Holliwell Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophy Am J Cardiol 69 1992 639 645
33. RH Fagard Reversibility of left ventricular hypertrophy by antihypertensive drugs Neth J Med 47 1995 173 179
34. M Shaki S Thom PS Sever RA Foale Regression of hypertensive left ventricular hypertrophy and left ventricular diastolic function Lancet 336 1990 458 461
35. BS Lewis A Shefer MY Flugelman A Merdler DA Halon R Hardoff Effect of the second-generation calcium channel blocking drug nisoldipine on diastolic left ventricular dysfunction in heart failure Am Heart J 118 1989 505 509
36. J Szlachic JF Tubau C Vollmer BM Massie Effect of diltiazem on left ventricular mass and diastolic filling in mild to moderate hypertension Am J Cardiol 63 1989 198 201
37. MD Guazzi M Alimento M Berti C Fiorentini C Galli G Tamborini Enhanced hypoxic pulmonary vasoconstriction in hypertension Circulation 79 1989 337 343
38. MD Guazzi A Polese A Bartorelli A Loaldi C Fiorentini Evidence of a shared mechanism of vasoconstriction in pulmonary and systemic circulation in hypertension: a possible role of intracellular calcium Circulation 66 1982 881 886
39. DC Wallerson RB Devereux Reproducibility of echocardiographic left ventricular measurements Hypertension 9 suppl II 1987 6 18
40. JS Gottdiener SV Livengood PS Meyer CA Chase Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function J Am Coll Cardiol 25 1995 424 430
41. D Levy RJ Garrison DD Savage WB Kannel WP Castelli Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study N Engl J Med 322 1990 1561 1566
42. ML Muiesan M Salvetti D Rizzon M Castellano F Donato E Agabiti-Rosei Association of changes of left ventricular mass to prognosis in hypertensive patients J Hypertens 13 1995 1091 1097